CRTonline - Android App    
Login  

Log In
 
 

Forgot Your Password?
 


Not a member? Click here!

Excimer Laser for the Treatment of Rescue AMI
Fondaparinux in ACS
Impact of Cilostazol on Platelet Function: First Report from the Placebo-Controlled Randomized OPTIMUS-2 Trial
Use of Laser in Rescue AMI
The Role of Adenosine as Adjunctive Therapy in Acute Myocardial Infarction

Poll Archives
 
















 
 

n-3 Fatty Acids – Failure of Concept or Execution?

Although n-3 fatty acids have been shown to confer benefits in patients with MI or heart failure, daily treatment with this compound does not appear to reduce CV morbidity or mortality in patients with multiple CV risk factors.

For more, click here

  

 
 

Advance III – A Case of Length Mattering

In patients requiring an ICD, the use of a long-detection interval programming system has been shown to result in a lower rate of ATP, shocks, and inappropriate shocks.

For more, click here

  

 
 

CKD Remains Critical in TAVI Success

A number of studies have identified CKD as an independent predictor of mortality following TAVI. This concept received further support from the PRAGMATIC-Plus initiative substudy, where CKD was shown to be associated with an increased risk of 1-year mortality after TAVI.

For more, click here

  

<
||
>
News Archive >




















Untitled Document

April 18, 2013

Paravalvular Leaks Post-Transcatheter Aortic Valve Replacement
- Philippe Généreux, MD


Background physiology and clinical experiences with iFR
- Justin E Davies, MD

4/8/2013		 Pre-Operative Anemia: Lessons from Surgery with Application to PCI?
Kathrine P Frey, MD

3/13/2013		 Drug-Eluting Coronary Artery Stents
Giulio G. Stefanini, MD

2/21/2013		 Balloon-pump assisted Coronary Intervention Study (BCIS-1): Long term Mortality Data
Prof. Simon Redwood, MD, et al.

2/18/2013		 Novel Stent Design & BioMimicry in DES
Sigmund Silber, MD, PhD

2/11/2013		 Treatment of Giant Coronary Aneurysms
Danny Dvir, MD

1/24/2013		 Low-Flow, Low-Gradient Aortic Stenosis with Normal and Preserved LVEF
Philippe Pibarot, MD


 Click here to visit the WEBEX archives

Effect of Intensive vs. Moderate Lipid-Lowering Therapy on Epicardial Adipose Tissue in Hyperlipidemic Post-Menopausal Women. A Substudy of the BELLES Trial (Beyond Endorsed Lipid Lowering with EBT Scanning).
N Alexopoulos, et al.
JACC 2013; 61:1956-1961
The Predictive Value of Short-Term Changes in Hemoglobin Concentration in Patients Presenting with Acute Decompensated Heart Failure.
P van der Meer, et al.
JACC 2013; 61:1973-1981
Effect of Long-Detection Interval vs. Standard-Detection Interval for Implantable Cardioverter-Defibrillators on Antitachycardia Pacing and Shock Delivery. The ADVANCE III Randomized Clinical Trial.
M Gasparini, et al.
JAMA 2013; 309:1903-1911
n–3 Fatty Acids in Patients with Multiple Cardiovascular Risk Factors.
The Risk and Prevention Study Collaborative Group.
NEJM 2013; 368:1800-1808
Cilostazol Reduces Angiographic Restenosis after Endovascular Therapy for Femoropopliteal Lesions in the Sufficient Treatment of Peripheral Intervention by Cilostazol (STOP-IC) Study.
O Lida, et al.
Circ 2013 Online
Neurologic Complications of Infective Endocarditis: Risk Factors, Outcome, and Impact of Cardiac Surgery: A Multicenter Observational Study.
E García-Cabrera, et al.
Circ 2013 Online
Impact of Catalytic Iron on Mortality in Patients with ACS Exposed to Iodinated Radiocontrast—The Iscom Study.
S Lele, et al.
AHJ 2013; 165:744-751
Impact of Preoperative CKD on Short- and Long-term Outcomes after TAVI: A Pooled-RotterdAm-Milano-Toulouse In Collaboration Plus (PRAGMATIC-Plus) Initiative
N Dumonteli, et al.
AHJ 2013; 165:752-760
Effects of Interleukin-1 Blockade with Anakinra on Adverse Cardiac Remodeling and Heart Failure after AMI [from the Virginia Commonwealth University-Anakinra Remodeling Trial (2) (VCU-ART2) Pilot Study].
AJC 2013; 111:1394-1400



Contribute to CardioTube >
Click Here to See More CardioTube Videos >

Treating CTOs: Is There Enough Evidence-Based Data or do We Need Further Randomized Clinical Trials?
Gerald S. Werner, MD, PhD
Indication for CTO PCI: Clinical Rationale and Appropriateness
J. Aaron Grantham, MD
Patient Selection for CTO Recanalization: What Are the Appropriate Criteria?
Tarek Helmy, MD

CRT2013
The RESOLUTE Program: today and tomorrow
Sigmund Silber, MD, PhD
RESOLUTE International Trial
F-J. Neumann, MD, et al.
Primary Results Following Percutaneous Coronary Intervention with the 38mm Resolute Zotarolimus-eluting Stent
Shirish Hiremath, MD, et al.
Two Year Outcomes Following Implantation of the Resolute Zotarolimus-eluting Stent in Small (less or equal to 2.5 mm) Vessels
Ronald Caputo, MD
Three-Year Outcomes From RESOLUTE All Comers Trial
Prof. Sigmund Silber, MD



5/7/2013		 AG Mednet Announces Partnership with The Methodist DeBakey Heart & Vascular Center Echocardiography Core Lab

5/7/2013		 Positron and Biologics Modular Enter into Co-Marketing Agreement

5/7/2013		 Cardium Announces Generx Publication In Molecular Therapy

5/7/2013		 Economic Growth In Latin America Fueling Strong Revenue Growth For Interventional Cardiology Devices

5/7/2013		 Atrium Medical Announces 1-year results of the INFUSE-AMI Trial

4/15/2013		 ACC Journal Publishes Outcomes of Diabetes Patients Treated with Medtronic's Resolute Stent
ACS & AMI
Angiomyogenesis & Cell Therapy
Carotid Interventions

Home | CRT2013 | CardioTube | Interesting Cases | Trials | Weekly Poll Archive | Newsletter Archive | Login


Copyright © 2013, CRTONLINE - About / Contact Us. All rights reserved. Privacy Policy
Powered by Multiweb